Skip to main content

ESC Guidelines for Carotid Sinus Hypersensitivity (CSH)

Carotid Sinus Hypersensitivity (CSH)

Definition

Carotid sinus hypersensitivity (CSH) is an exaggerated response to carotid sinus stimulation leading to:


• Excessive bradycardia (cardioinhibitory response)

• Hypotension (vasodepressor response)

• Or a combination of both


It is an important cause of unexplained syncope, especially in elderly patients.



---


Anatomy and Physiology of the Carotid Sinus


• Located at the bifurcation of the common carotid artery

• Contains baroreceptors sensitive to stretch

• Afferent pathway: Glossopharyngeal nerve (Hering’s nerve)

• Central integration: Medulla

• Efferent pathway: Vagus nerve → SA/AV node


Normal function: Maintains blood pressure homeostasis

In CSH: Minor stimulation → exaggerated reflex



---


Epidemiology


• More common in age > 60 years

• Male predominance

• Frequently associated with hypertension

• Seen in patients with recurrent unexplained falls


CSH may be present in asymptomatic elderly individuals, so clinical correlation is essential.



---


Pathophysiology


Exaggerated baroreceptor reflex leads to:


1. Increased vagal tone → sinus arrest / AV block



2. Sympathetic withdrawal → vasodilation → hypotension




Even mild external pressure (tight collar, shaving, neck turning) can trigger symptoms.



---


Types of Carotid Sinus Hypersensitivity


1. Cardioinhibitory Type


• Asystole ≥ 3 seconds during carotid sinus massage

• Predominantly bradycardia-mediated syncope

• Most common type


2. Vasodepressor Type


• Drop in systolic BP ≥ 50 mmHg

• Minimal heart rate change

• Syncope due to hypotension


3. Mixed Type


• Both significant asystole and hypotension



---


Clinical Presentation


• Recurrent syncope

• Presyncope

• Unexplained falls in elderly

• Syncope triggered by: – Shaving

– Tight collars

– Neck rotation

– Carotid sinus pressure


Often abrupt, with rapid recovery.



---


Diagnosis


Carotid Sinus Massage (CSM)


Performed under continuous ECG and BP monitoring.


Technique: • Supine position

• Massage one side at a time

• 5–10 seconds duration

• Repeat in upright position if negative


Diagnostic Criteria: • Asystole ≥ 3 sec

OR

• SBP drop ≥ 50 mmHg

With reproduction of symptoms


Contraindications: • Recent TIA or stroke (<3 months)

• Significant carotid stenosis

• Carotid bruit (relative)



---


Differential Diagnosis


• Vasovagal syncope

• Orthostatic hypotension

• AV block

• Sick sinus syndrome

• Arrhythmias

• Structural heart disease



---


Management


1. Conservative Measures


• Avoid tight collars

• Avoid neck pressure

• Treat hypertension carefully

• Patient education


2. Permanent Pacemaker


Indicated in:


• Symptomatic cardioinhibitory CSH

• Recurrent syncope with documented asystole


Preferred mode: • Dual chamber pacing (DDD)


Pacemaker is less effective in pure vasodepressor type.



---


Prognosis


• Generally benign in terms of mortality

• Morbidity due to falls and trauma

• Pacemaker significantly reduces recurrence in cardioinhibitory type



---


Important Clinical Pearls


• Always perform CSM in unexplained syncope in elderly (if no contraindications)

• Asymptomatic CSH does not require treatment

• Mixed type may still benefit from pacing

• Reproduction of symptoms during CSM is crucial for diagnosis



---


Quick Exam Revision Table


Feature Cardioinhibitory Vasodepressor Mixed


Asystole ≥ 3 sec Yes No Yes

SBP drop ≥ 50 mmHg May Yes Yes

Pacemaker benefit High Low Moderate




---


Carotid sinus hypersensitivity is an important, often under-recognized cause of syncope in elderly patients. Proper bedside testing and correct phenotyping guide management, particularly when considering permanent pacing.


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.